SCHEMBL17875845

SCHEMBL17875845

c1ccc2c(c1)oc1cc(-c3ccc4c(c3)-c3ccc(-c5cccc6oc7ccccc7c56)cc3COC4)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.39
ALOX5 P09917 2/20 0.36
HCRTR1 O43613 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
ATM Q13315 1/20 0.35
AHR P35869 2/20 0.35
HSP90AA1 P07900 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875834 1.00 PRKDC (0.39) PRKDCALOX5HCRTR1NPC1RAB9A
SCHEMBL17875895 0.95 PRKDC (0.41) PRKDCALOX5HCRTR1NPC1RAB9A
SCHEMBL17875847 0.94 HSP90AA1 (0.38) PRKDCALOX5HSP90AA1MAPTKDM4E
SCHEMBL17875848 0.93 ALOX5 (0.36) PRKDCALOX5NPC1RAB9AAHR
SCHEMBL17875839 0.93 ALOX5 (0.36) PRKDCALOX5NPC1RAB9AAHR
SCHEMBL17875831 0.92 AHR (0.41) PRKDCALOX5HCRTR1NPC1RAB9A
SCHEMBL17875850 0.90 PLA2G2A (0.36) PRKDCALOX5NPC1RAB9AATM
SCHEMBL17875833 0.90 PRKDC (0.49) PRKDCALOX5HCRTR1NPC1RAB9A
SCHEMBL17875859 0.90 PLA2G2A (0.36) PRKDCALOX5NPC1RAB9AATM
SCHEMBL17875829 0.90 ALOX5 (0.49) PRKDCALOX5ATMHSP90AA1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PRKDC 4858/4885ALOX5 3059/4885HCRTR1 214/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PRKDC 4858/4885ALOX5 3059/4885HCRTR1 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.